An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family

Retrovirology

Volumn 6, Issue , 2009, Pages 95-

  Craigo, Jodi K ^a,b   Barnes, Shannon ^a,b   Zhang, Baoshan ^a,b   Cook, Sheila J ^c   Howe, Laryssa ^b   Issel, Charles J ^c   Montelaro, Ronald C ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; EQUINE INFECTIOUS ANEMIA VIRUS; GENE SEQUENCE; NONHUMAN; PROTEIN SECONDARY STRUCTURE; SEROLOGY; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CROSS REACTIONS; EQUINE INFECTIOUS ANEMIA; GENETIC VARIATION; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; PENNSYLVANIA; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUINE LENTIVIRUSES; LENTIVIRUS;

EID: 70450227341     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-95     Document Type: Article

References (58)

1. Issel CJ, Foil LD. Studies on equine infectious anemia virus transmission by insects. J Am Vet Med Assoc 1984, 184:293-297.
2. Leroux C, Cadore JL, Montelaro RC. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?. Vet Res 2004, 35:485-512. 10.1051/vetres:2004020, 15236678.
3. APHIS Equine Infectious Anemia (EIA). (USDA ed.: Veternairy Services) 2006,
4. Craigo JK, Montelaro RC. Equine Infectious Anemia Virus (Retroviridae). Encyclopedia of Virology 2008, 2:167-174. Academic Press, Third, [Mahy BWJ, Regenmortel MHVv (Series Editor).
5. Hammond SA, Li F, McKeon BM, Cook SJ, Issel CJ, Montelaro RC. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J Virol 2000, 74:5968-5981. 10.1128/JVI.74.7.3112-3121.2000, 112093, 10846078.
6. Harrold SM, Cook SJ, Cook RF, Rushlow KE, Issel CJ, Montelaro RC. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. J Virol 2000, 74:3112-3121. 111810, 10708426.
7. Montelaro RC, Ball JM, Rushlow K. Equine retroviruses. The Retroviridae 1993, 2:257-360. New York, N.Y.: Plenum Press, Levy JA.
8. Craigo JK, Leroux C, Howe L, Steckbeck JD, Cook SJ, Issel CJ, Montelaro RC. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. Journal of General Virology 2002, 83:1353-1359.
9. Kono Y, hirasawa K, Fukunaga Y, Taniguchi T. Recrudesence of equine infectious anemia by treatment with immunosuppressive drugs. Nat Inst Anim Hlth Quart 1976, 16:8-15.
10. APHIS Equine Infectious Anemia. (USDA ed.: Veternairy Services) 2003,
11. Craigo JK, Sturgeon TJ, Cook SJ, Issel CJ, Leroux C, Montelaro RC. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Virology 2006, 344:340-353.
12. Leroux C, Craigo JK, Issel CJ, Montelaro RC. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies. J Virol 2001, 75:4570-4583. 114210, 11312327.
13. Leroux C, Issel C, Montelaro RC. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J Virol 1997, 71:9627-9639. 230271, 9371627.
14. Lichtenstein DL, Issel CJ, Montelaro RC. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. J Virol 1996, 70:3346-3354. 10.1016/S0168-1702(00)00147-7, 190205, 8648664.
15. Zheng YH, Nakaya T, Sentsui H, Kameoka M, Kishi M, Hagiwara K, takahashi H, Kono Y, Ikuta K. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anemia virus during febrile episodes in an experimentally infected horse. Journal of General Virology 1997, 78:807-820.
16. Zheng YH, Sentsui H, Kono Y, Ikuta K. Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages. Virus Res 2000, 68(1):93-98. 10.1007/BF01309743, 10930666.
17. Zheng YH, Sentsui H, Nakaya T, Kono Y, Ikuta K. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain. J Virol 1997, 71:5031-5039. 10.1006/viro.1995.1532, 191736, 9188568.
18. Greene WK, Meers J, del Fierro G, Carnegie PR, Robinson WF. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats. Arch Virol 1993, 133:51-62. 10.1016/0092-8674(86)90778-6, 8240017.
19. Suarez DL, Whetstone CA. Identification of hypervariable and conserved regions in the surface envelope gene in the bovine lentivirus. Virology 1995, 212:728-733.
20. Starcich ES, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986, 45:637-648.
21. Simmonds P, Balfe P, Ludlam J, Bishop O, Brown AJ. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 1990, 64:5840-5850. 10.1099/0022-1317-75-2-425, 248744, 2243378.
22. Issel CJ, Horohov DW, Lea DF, Adams WV, Hagius SD, McManus JM, Allison AC, Montelaro RC. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol 1992, 66:3398-3408. 10.1007/BF01311054, 241120, 1316455.
23. Payne SL, Rausch J, Rushlow K, Montelaro RC, Issel C, Flaherty M, Perry S, Sellon D, Fuller F. Characterization of infectious molecular clones of equine infectious anaemia virus. J Gen Virol 1994, 75(Pt 2):425-429.
24. Rwambo PM, Issel CJ, Adams WV, Hussain KA, Miller M, Montelaro RC. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch Virol 1990, 111:199-212.
25. Cole KS, Murphey-Corb M, Narayan O, Joag SV, Shaw GM, Montelaro RC. Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1†Infections. J Virol 1998, 72:7852-7859. 110105, 9733822.
26. Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, Montelaro RC. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 1997, 71:5069-5079. 191740, 9188572.
27. Hammond SA, Cook SJ, Lichtenstein DL, Issel CJ, Montelaro RC. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol 1997, 71:3840-3852. 191535, 9094660.
28. Montelaro RC, Cole KS, Hammond SA. Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development. AIDS Res Hum Retroviruses 1998, 14(Suppl 3):S255-S259. 10.1016/0042-6822(87)90124-3, 9814952.
29. Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J Virol 1986, 57:71-80. 252700, 3001367.
30. Payne SL, Fang FD, Liu CP, Dhruva BR, Rwambo P, Issel CJ, Montelaro RC. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology 1987, 161:321-331. 10.1016/0042-6822(89)90203-1, 2825406.
31. Payne SL, Salinovich O, Nauman SM, Issel CJ, Montelaro RC. Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J Virol 1987, 61:1266-1270. 254092, 3029423.
32. Payne SL, Rushlow K, Dhruva BR, Issel CJ, Montelaro RC. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Virology 1989, 172:609-615. 10.1006/viro.1999.9921, 2552661.
33. Lichtenstein DL, Rushlow KE, Cook RF, Raabe ML, Swardson CJ, Kociba GJ, Issel CJ, Montelaro RC. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J Virol 1995, 69:2881-2888. 10.1016/S0042-6822(03)00168-5, 188985, 7707512.
34. Lichtenstein DL, Craigo JK, Leroux C, Rushlow KE, Cook RF, Cook SJ, Issel CJ, Montelaro RC. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Virology 1999, 263:408-417. 10.1006/viro.1999.9939, 10544113.
35. Reis JKP, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies. Virology 2003, 311:169-180. 10.1006/viro.1998.9550, 12832214.
36. Hammond SA, Raabe ML, Issel CJ, Montelaro RC. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology 1999, 262:416-430. 10.1128/JVI.77.13.7244-7253.2003, 10502520.
37. Hammond SA, Cook SJ, Falo LD, Issel CJ, Montelaro RC. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology 1999, 254:37-49. 10.1128/JVI.79.5.2666-2677.2005, 9927572.
38. Li F, Craigo JK, Howe L, Steckbeck JD, Cook S, Issel C, Montelaro RC. A Live Attenuated Equine Infectious Anemia Virus Proviral Vaccine with a Modified S2 Gene Provides Protection from Detectable Infection by Intravenous Virulent Virus Challenge of Experimentally Inoculated Horses. Jf Virol 2003, 77:7244-7253.
39. Craigo JK, Li F, Steckbeck JD, Durkin S, Howe L, Cook SJ, Issel C, Montelaro RC. Discerning an Effective Balance between Equine Infectious Anemia Virus Attenuation and Vaccine Efficacy. J Virol 2005, 79:2666-2677. 10.1016/j.vaccine.2006.09.040, 548432, 15708986.
40. Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus. J Gen Virol 2007, 88:1324-1336. 10.1073/pnas.0706449104, 17374779.
41. Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. Vaccine 2007, 25:834-845. 10.1128/JVI.02028-07, 1855206, 17023099.
42. Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proceedings of the National Academy of Sciences 2007, 104:15105-15110.
43. Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. J Virol 2008, 82:4052-4063. 10.1128/JVI.75.13.5721-5729.2001, 2292999, 18234792.
44. Burns DP, Collignon C, Desrosiers RC. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. JVirol 1993, 67:4104-4113.
45. Moore JP, Parren PWHI, Burton DR. Genetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development. The Journal of Virology 2001, 75:5721-5729.
46. Levy JA. HIV pathogenesis: knowledge gained after two decades of research. Adv Dent Res 2006, 19:10-16. 10.1016/j.virol.2003.09.047, 16672543.
47. Pisoni G, Quasso A, Moroni P. Phylogenetic analysis of small-ruminant lentivirus subtype B1 in mixed flocks: evidence for natural transmission from goats to sheep. Virology 2005, 339:147-152.
48. Shah C, Bni, Huder JB, Vogt H-R, Mhlherr J, Zanoni R, Miserez R, Lutz H, Schupbach J. Phylogenetic analysis and reclassification of caprine and ovine lentiviruses based on 104 new isolates: evidence for regular sheep-to-goat transmission and worldwide propagation through livestock trade. Virology 2004, 319:12-26. 10.1016/j.coi.2006.05.012, 14967484.
49. Zanoni RG. Phylogenetic analysis of small ruminant lentiviruses. J Gen Virol 1998, 79(Pt 8):1951-1961. 10.1016/j.vetimm.2008.01.007, 9714243.
50. Brander C, Frahm N, Walker BD. The challenges of host and viral diversity in HIV vaccine design. Curr Opin Immunol 2006, 18:430-437.
51. Elder JH, Sundstrom M, de Rozieres S, de Parseval A, Grant CK, Lin Y-C. Molecular mechanisms of FIV infection. Veterinary Immunology and Immunopathology 2008, 123:3-13. 10.1016/S0166-0934(02)00101-5, 2409060, 18289701.
52. Coggins L, Norcross NL. Immunodiffusion reaction in equine infectious anemia. Cornell Vet 1970, 60:330-335. 10.1016/S0042-6822(03)00351-9, 4986043.
53. Cook RF, Cook SJ, Li FL, Montelaro RC, Issel CJ. Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV). J Virol Methods 2002, 105:171-179. 10.1099/0022-1317-77-3-435, 12176154.
54. Group GC Program manual for the Wisconsin Package. 1994, Madison, Wis: Genetics Computer Group.
55. Swofford DL. PAUP: Phylogenetic Analysis Using Parsimony and Other Methods. 2001, Sunderlan, MA: Sinauer Associates.
56. Cook RF, Cook SJ, Berger SL, Leroux C, Ghabrial NN, Gantz M, Bolin PS, Mousel MR, Montelaro RC, Issel CJ. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides. Virology 2003, 313:588-603.
57. Maniatis T, Fritsch EF, Sambrook JE. Molecular cloning: a laboratory manual 1982, Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.
58. Grund CH, Lechman ER, Pezzuolo NA, Issel CJ, Montelaro RC. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies. J Gen Virol 1996, 77(Pt 3):435-442.